In a recent health advisory, the CDC provided background and recommendations on rebound of COVID-19 symptoms and positive tests after a course of Paxlovid, an oral antiviral drug authorized for treating COVID-19. Patients may report return of symptoms and positive test results two to eight days after they complete a course of Paxlovid, and this lasted a median of three days. Based on data available at this time, patient monitoring and an additional period of isolation continue to be the most appropriate management for patients with recurrence of symptoms after completion of a treatment course of Paxlovid. A second course is NOT recommended at this time. Symptoms that persist or worsen should be checked out by a physician. Read the full advisory here.
NCPA
